Overview

A Pilot Study of the Safety and Efficacy of Abatacept Injections in the Treatment of Behcet's Syndrome

Status:
Completed
Trial end date:
2018-12-28
Target enrollment:
Participant gender:
Summary
Hypothesis: Abatacept injections will decrease the number of oral ulcers seen in Behcet's patients
Phase:
Early Phase 1
Details
Lead Sponsor:
New York University School of Medicine
NYU Langone Health
Collaborator:
Bristol-Myers Squibb
Treatments:
Abatacept